Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Name: Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free
Brand: Antibodies.com
SKU: A338731
Price: 326.0 GBP
Availability: InStock

Enlarge Image

$456

Human monoclonal antibody to C5. Research grade Tesidolumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

100% Guarantee

Price Match Guarantee

Shipping Information

Freight/Packing Charges: $40

Dispatched from St. Louis, MO.

Lead Time: 7-10 business days.

Specifications

Name

Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Description

Human monoclonal antibody to C5. Research grade Tesidolumab biosimilar.

Applications

ELISA, Flow Cytometry, Functional Studies, in vivo Research

Reactivity

Human

Host

Human

Clonality

Monoclonal

Isotype

IgG1

Conjugate

Unconjugated

Purity

The purity of this Biosimilar is >95%, as determined by SDS-PAGE.

Product Form

Liquid

Formulation

Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.

Storage

Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).

Synonyms

C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4, Complement C5, CPAMD4

Suitable Secondaries

See all Anti-Human IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (3)

Enlarge Image

SDS-PAGE - Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

SDS-PAGE for Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731).

Enlarge Image

Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Dose-response for Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731).

Enlarge Image

Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Chromatography profile for Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731).

Publishing research using Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)? Please let us know so that we can list the citation on this page.

Alternative products to Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

(3)

A323692

Ravulizumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(3)

A323409

Eculizumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(2)

A323775

Tesidolumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Kinetics (BLI), Kinetics (SPR) and Functional Assay.

(2)

A323828

Vilobelimab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant chimeric monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(3)

A339026

Ravulizumab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Ravulizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(3)

A338972

Eculizumab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Eculizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(3)

A338730

Olendalizumab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Olendalizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(2)

A338732

Crovalimab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Crovalimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(2)

A323375

Crovalimab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(2)

A323537

Lendalizumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(2)

A323674

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

A340606

Omoprubart Biosimilar - Anti-C5 Antibody - BSA and Azide free

Human monoclonal antibody to C5 Research grade Omoprubart biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(3)

A323692

Ravulizumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(3)

A323409

Eculizumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(2)

A323775

Tesidolumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Kinetics (BLI), Kinetics (SPR) and Functional Assay.

(2)

A323828

Vilobelimab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant chimeric monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(3)

A339026

Ravulizumab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Ravulizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(3)

A338972

Eculizumab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Eculizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(3)

A338730

Olendalizumab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Olendalizumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(2)

A338732

Crovalimab Biosimilar - Anti-C5 Antibody - BSA and Azide free

Humanized monoclonal antibody to C5 Research grade Crovalimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

(2)

A323375

Crovalimab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(2)

A323537

Lendalizumab Biosimilar - Anti-C5 Antibody - Low endotoxin, Azide free

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

(2)

A323674

Recombinant human monoclonal antibody to C5 for ELISA, FACS, Functional Assay and In Vivo.

A340606

Omoprubart Biosimilar - Anti-C5 Antibody - BSA and Azide free

Human monoclonal antibody to C5 Research grade Omoprubart biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

See all C5 Antibodies

Proteins predicted to interact with C5

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.

C8 Antibodies

99.9% Relevancy Score

C5aR Antibodies

99.9% Relevancy Score

C6 Antibodies

99.9% Relevancy Score

C9 Antibodies

99.9% Relevancy Score

C7 Antibodies

99.9% Relevancy Score

GPCR C5L2 Antibodies

99% Relevancy Score

C3 Antibodies

97.4% Relevancy Score

Prothrombin Antibodies

92.1% Relevancy Score

VDAC1 Antibodies

90.1% Relevancy Score

ISO 9001:2015 Certified

Live Customer Support

4.5/5 on Trustpilot

100% Quality Guarantee

Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Human monoclonal antibody to C5. Research grade Tesidolumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

Specifications

Scientific Validation DataValidation Data (3)

SDS-PAGE - Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Alternative products to Tesidolumab Biosimilar - Anti-C5 Antibody - BSA and Azide free (A338731)

Proteins predicted to interact with C5